pI: 6.2447 |
Length (AA): 1343 |
MW (Da): 147262 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 19 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
44 | 185 | 1a17 () | 28 | 173 | 26.00 | 0 | 1 | 0.46 | -0.75 |
44 | 126 | 1w3b (A) | 317 | 399 | 19.00 | 0.00000066 | 0.53 | 0.44 | -1.61 |
466 | 932 | 1qcf (A) | 87 | 531 | 16.00 | 0 | 1 | 0.4 | 0.47 |
644 | 923 | 1phk () | 16 | 290 | 24.00 | 0 | 1 | 0.52 | -1.13 |
647 | 985 | 1kob (A) | 53 | 373 | 22.00 | 0 | 1 | 0.53 | -0.69 |
938 | 1336 | 1nd7 (A) | 544 | 916 | 21.00 | 0 | 1 | 0.49 | -0.44 |
37 | 164 | 3sz7 (A) | 107 | 234 | 29.00 | 0 | 1 | 0.570409 | -1.11 |
41 | 163 | 3upv (A) | 259 | 381 | 25.00 | 0 | 1 | 0.492086 | -1.22 |
44 | 231 | 4ja7 (A) | 28 | 209 | 24.00 | 0 | 1 | 0.326085 | 0.38 |
48 | 122 | 4cgu (A) | 8 | 88 | 36.00 | 0.017 | 0.82 | 0.320645 | -0.1 |
429 | 784 | 4o1p (A) | 146 | 501 | 21.00 | 0.00000000063 | 0.81 | 0.280178 | 1.3 |
496 | 962 | 3pvu (A) | 40 | 519 | 19.00 | 0 | 1 | 0.453829 | 0.48 |
641 | 910 | 3g2f (A) | 197 | 493 | 30.00 | 0 | 1 | 0.350142 | 0.05 |
643 | 1031 | 2rio (A) | 12 | 421 | 22.00 | 0 | 1 | 0.34075 | 0.73 |
685 | 940 | 4fgb (A) | 53 | 297 | 27.00 | 0.0000000021 | 1 | 0.469418 | -0.46 |
748 | 853 | 4wnk (A) | 294 | 378 | 41.00 | 0.021 | 0.88 | 0.250728 | 0.29 |
921 | 1335 | 3olm (A) | 415 | 802 | 19.00 | 0 | 1 | 0.36211 | 0.51 |
963 | 1336 | 1c4z (A) | 502 | 846 | 28.00 | 0 | 1 | 0.429281 | 0.72 |
1247 | 1333 | 3pt3 (A) | 2702 | 2791 | 23.00 | 0 | 0.58 | 0.27728 | -1.16 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | metacyclic. | Fernandes MC |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | amastigotes. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_163570)
Species | Accession | Gene Product |
---|---|---|
Dictyostelium discoideum | DDB_G0276527 | CAMKL family protein kinase |
Leishmania braziliensis | LbrM.34.3980 | protein kinase, putative,MAP kinase kinase-like protein |
Leishmania donovani | LdBPK_354050.1 | protein kinase, putative |
Leishmania infantum | LinJ.35.4050 | protein kinase, putative,MAP kinase kinase-like protein |
Leishmania major | LmjF.35.4000 | protein kinase, putative,MAP kinase kinase-like protein |
Leishmania mexicana | LmxM.34.4000 | protein kinase, putative,MAP kinase kinase-like protein |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.5
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Zea mays | Casein kinase II alpha | 332 aa | 21.6% | 268 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 26.1% | 307 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 27.6% | 279 aa | Compounds | References |
Rattus norvegicus | MAP kinase p38 alpha | 360 aa | 24.7% | 308 aa | Compounds | References |
Schizosaccharomyces pombe 972h- | Casein kinase II subunit alpha | 332 aa | 22.1% | 290 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 24.5% | 278 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 24.4% | 299 aa | Compounds | References |
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 29.8% | 168 aa | Compounds | References |